Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

21. März 2019 INDIZES USA

Endologix, Inc. (Nasdaq:ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders …
(Orginal – Story lesen…)